Acurx Pharmaceuticals
ACXP
ACXP
23 hedge funds and large institutions have $4.24M invested in Acurx Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 7 closing their positions.
Holders
23
Holders Change
+5
Holders Change %
+27.78%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
1
Closed
7
Calls
$284K
Puts
$822K
Net Calls
-$538K
Net Calls Change
-$538K
Top Buyers
Top Sellers
| 1 |
AC
1
Armistice Capital
New York
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
3
Millennium Management
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$52.5K |
| 5 |
TSS
5
Two Sigma Securities
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TSS
26
Two Sigma Securities
New York
| – | – | -10,105 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | – | -7,097 | Closed |
|
|
AIM
28
Anchor Investment Management
Columbia,
South Carolina
| – | – | -4,500 | Closed |
|
29
Group One Trading
Chicago,
Illinois
| – | – | -600 | Closed |
|
|
CFGS
30
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
31
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ACM
32
Altium Capital Management
New York
| – | – | – | – |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 53 | +22 | +71% |
|